{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T01:34:03Z","timestamp":1790213643551,"version":"4.1.0"},"reference-count":23,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:00:00Z","timestamp":1559347200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:00:00Z","timestamp":1559347200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Antimicrobial Agents"],"published-print":{"date-parts":[[2019,6]]},"DOI":"10.1016\/j.ijantimicag.2019.02.019","type":"journal-article","created":{"date-parts":[[2019,3,2]],"date-time":"2019-03-02T00:00:01Z","timestamp":1551484801000},"page":"789-794","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"title":["Echinocandins vs. amphotericin B against invasive candidiasis in children and neonates: A meta-analysis of randomized controlled trials"],"prefix":"10.1016","volume":"53","author":[{"given":"Yu-Hung","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I-Ling","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6334-2388","authenticated-orcid":false,"given":"Chih-Cheng","family":"Lai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hung-Jen","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijantimicag.2019.02.019_bib0001","article-title":"Pediatric invasive candidiasis: epidemiology and diagnosis in children","volume":"2","author":"Steinbach","year":"2016","journal-title":"J Fungi (Basel)"},{"key":"10.1016\/j.ijantimicag.2019.02.019_bib0002","doi-asserted-by":"crossref","first-page":"S12","DOI":"10.1093\/jpids\/pix053","article-title":"Recognition and clinical presentation of invasive fungal disease in neonates and children","volume":"6","author":"King","year":"2017","journal-title":"J Pediatric Infect Dis Soc"},{"key":"10.1016\/j.ijantimicag.2019.02.019_bib0003","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1007\/s12281-016-0252-7","article-title":"The European Paediatric Mycology Network (EPMyN): Towards a better understanding and management of fungal infections in children","volume":"10","author":"Warris","year":"2016","journal-title":"Curr Fungal Infect Rep"},{"key":"10.1016\/j.ijantimicag.2019.02.019_bib0004","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1086\/496922","article-title":"The epidemiology and attributable outcomes of candidemia in adults and children hospitalized in the United States: a propensity analysis","volume":"41","author":"Zaoutis","year":"2005","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2019.02.019_bib0005","doi-asserted-by":"crossref","first-page":"e38","DOI":"10.1086\/655698","article-title":"Risk factors and predictors for candidemia in pediatric intensive care unit patients: implications for prevention","volume":"51","author":"Zaoutis","year":"2010","journal-title":"Clin Infect Dis"},{"issue":"Suppl 7","key":"10.1016\/j.ijantimicag.2019.02.019_bib0006","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1111\/1469-0691.12039","article-title":"ESCMID* guideline for the diagnosis and management of Candida diseases 2012: non-neutropenic adult patients","volume":"18","author":"Cornely","year":"2012","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.ijantimicag.2019.02.019_bib0007","doi-asserted-by":"crossref","first-page":"2092","DOI":"10.1007\/s00134-013-3109-3","article-title":"A research agenda on the management of intra-abdominal candidiasis: results from a consensus of multinational experts","volume":"39","author":"Bassetti","year":"2013","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.ijantimicag.2019.02.019_bib0008","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1007\/s15010-013-0558-0","article-title":"An Italian consensus for invasive candidiasis management (ITALIC)","volume":"42","author":"Scudeller","year":"2014","journal-title":"Infection"},{"key":"10.1016\/j.ijantimicag.2019.02.019_bib0009","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1093\/cid\/civ933","article-title":"Clinical practice guideline for the management of candidiasis: 2016 update by the Infectious Diseases Society of America","volume":"62","author":"Pappas","year":"2016","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2019.02.019_bib0010","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jmii.2017.07.006","article-title":"2016 guidelines for the use of antifungal agents in patients with invasive fungal diseases in Taiwan","volume":"51","author":"Kung","year":"2018","journal-title":"J Microbiol Immunol Infect"},{"key":"10.1016\/j.ijantimicag.2019.02.019_bib0011","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1186\/s12879-014-0725-7","article-title":"Micafungin for the treatment of proven and suspected invasive candidiasis in children and adults: findings from a multicenter prospective observational study","volume":"14","author":"Viscoli","year":"2014","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.ijantimicag.2019.02.019_bib0012","doi-asserted-by":"crossref","first-page":"e285","DOI":"10.1097\/MPH.0000000000000343","article-title":"Safety and effectiveness of micafungin in Japanese pediatric patients: results of a postmarketing surveillance study","volume":"37","author":"Kobayashi","year":"2015","journal-title":"J Pediatr Hematol Oncol"},{"key":"10.1016\/j.ijantimicag.2019.02.019_bib0013","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/j.jiac.2015.01.009","article-title":"Pharmacokinetics, efficacy, and safety of caspofungin in Japanese pediatric patients with invasive candidiasis and invasive aspergillosis","volume":"21","author":"Mori","year":"2015","journal-title":"J Infect Chemother"},{"key":"10.1016\/j.ijantimicag.2019.02.019_bib0014","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1542\/peds.2008-1158","article-title":"A prospective, multicenter study of caspofungin for the treatment of documented candida or aspergillus infections in pediatric patients","volume":"123","author":"Zaoutis","year":"2009","journal-title":"Pediatrics"},{"key":"10.1016\/j.ijantimicag.2019.02.019_bib0015","doi-asserted-by":"crossref","first-page":"d5928","DOI":"10.1136\/bmj.d5928","article-title":"The Cochrane Collaboration's tool for assessing risk of bias in randomised trials","volume":"343","author":"Higgins","year":"2011","journal-title":"BMJ"},{"key":"10.1016\/j.ijantimicag.2019.02.019_bib0016","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1097\/INF.0b013e3181da2171","article-title":"A randomized, double-blind, multicenter study of caspofungin versus liposomal amphotericin B for empiric antifungal therapy in pediatric patients with persistent fever and neutropenia","volume":"29","author":"Maertens","year":"2010","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.ijantimicag.2019.02.019_bib0017","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1111\/j.1365-2141.2012.09156.x","article-title":"A prospective, randomized study of empirical antifungal therapy for the treatment of chemotherapy-induced febrile neutropenia in children","volume":"158","author":"Caselli","year":"2012","journal-title":"Br J Haematol"},{"key":"10.1016\/j.ijantimicag.2019.02.019_bib0018","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1097\/INF.0000000000001996","article-title":"A phase 3 study of micafungin versus amphotericin B deoxycholate in infants with invasive candidiasis","volume":"37","author":"Benjamin","year":"2018","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.ijantimicag.2019.02.019_bib0019","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1097\/INF.0b013e31817275e6","article-title":"Micafungin versus liposomal amphotericin B for pediatric patients with invasive candidiasis: substudy of a randomized double-blind trial","volume":"27","author":"Queiroz-Telles","year":"2008","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.ijantimicag.2019.02.019_bib0020","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1093\/tropej\/fmr025","article-title":"A randomized, double-blind, prospective study of caspofungin vs. amphotericin B for the treatment of invasive candidiasis in newborn infants","volume":"58","author":"Mohamed","year":"2012","journal-title":"J Trop Pediatr"},{"key":"10.1016\/j.ijantimicag.2019.02.019_bib0021","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1097\/INF.0000000000002032","article-title":"Efficacy and safety of echinocandins for the treatment of invasive candidiasis in children: A meta-analysis","volume":"38","author":"Tsekoura","year":"2019","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.ijantimicag.2019.02.019_bib0022","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/j.ijantimicag.2015.08.009","article-title":"Assessment of echinocandin regimens by pharmacokinetic\/pharmacodynamic analysis against Candida spp. in paediatric patients","volume":"46","author":"Xu","year":"2015","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.ijantimicag.2019.02.019_bib0023","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1016\/j.jmii.2014.07.007","article-title":"Antimicrobial susceptibility and clinical outcomes of Candida parapsilosis bloodstream infections in a tertiary teaching hospital in Northern Taiwan","volume":"48","author":"Lin","year":"2015","journal-title":"J Microbiol Immunol Infect"}],"container-title":["International Journal of Antimicrobial Agents"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857919300494?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857919300494?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,13]],"date-time":"2025-10-13T17:34:17Z","timestamp":1760376857000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0924857919300494"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6]]},"references-count":23,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2019,6]]}},"alternative-id":["S0924857919300494"],"URL":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2019.02.019","relation":{},"ISSN":["0924-8579"],"issn-type":[{"value":"0924-8579","type":"print"}],"subject":[],"published":{"date-parts":[[2019,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Echinocandins vs. amphotericin B against invasive candidiasis in children and neonates: A meta-analysis of randomized controlled trials","name":"articletitle","label":"Article Title"},{"value":"International Journal of Antimicrobial Agents","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2019.02.019","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier B.V. and International Society of Chemotherapy. All rights reserved.","name":"copyright","label":"Copyright"}]}}